EYESW - (Second Sight Medical Products Inc.)

 EYESWのチャート


 EYESWの企業情報

symbol EYESW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear ―年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/eyesw
adr_tso
EBITDA EBITDA ー
終値(lastsale) 0.45
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 EYESWのテクニカル分析


 EYESWのニュース

   Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing  2022/03/22 13:27:46 Seeking Alpha
   Go read this dystopian story about patients whose bionic eyes went obsolete  2022/02/16 20:41:55 The Verge
A patient with the Argus II. | Photo by Dunyagoz Hospital/Anadolu Agency/Getty Images More than 350 blind people around the world have implants in their eyes made by the company Second Sight Medical Products , which could help partially restore aspects of sight. But the company abandoned the technology a few years ago when it was teetering on the verge of bankruptcy, according to a new investigation from IEEE Spectrum . Now, if something goes wrong with the implants, users are left stranded. “It is fantastic technology and a lousy company,” Ross Doerr, a Second Sight patient, told IEEE Spectrum . Second Sight’s implants, the Argus I and the Argus II, don’t restore normal vision; people see things in shades of gray that disappear when they move their heads. And results vary from person to person. Some users of the implants, which rolled out a decade ago, have struggled to make out even basic shapes. Others are now able to do things like ski. People who received the implants were told that there would be future updates and improvements to the technology, like software updates to boost the number of pixels in the system and thermal imaging, IEEE Spectrum reported this week.
   Haemonetics, Second Sight top healthcare gainers; Pulse, Karyopharm lead losers  2022/02/08 15:01:31 Seeking Alpha
Haemonetics HAE +13%. Second Sight Medical Products EYES +8%. Pulse Biosciences (PLSE) -36%. Karyopharm Therapeutics KPTI -22%.
   Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical  2022/02/08 11:33:09 Benzinga
Second Sight Medical Products Inc (NASDAQ: EYES ) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction . Second Sight Medical develops implantable visual prosthetics. Under the agreement, Nano Precision Medical will merge with a wholly-owned subsidiary of Second Sight . The surviving company Nano Precision Medical will be owned by Second Sight. The newly-formed merged company will focus on developing innovative implants Full story available on Benzinga.com
   Second Sight Medical Products to acquire Nano Precision Medical in all-stock deal  2022/02/07 21:53:18 Seeking Alpha
Second Sight Medical Products (EYES) will acquire Nano Precision Medical (NPM) and merge it with a wholly-owned subsidiary in an all-stock transaction.EYES will issue ~134M shares…
   Go read this dystopian story about patients whose bionic eyes went obsolete  2022/02/16 20:41:55 The Verge
A patient with the Argus II. | Photo by Dunyagoz Hospital/Anadolu Agency/Getty Images More than 350 blind people around the world have implants in their eyes made by the company Second Sight Medical Products , which could help partially restore aspects of sight. But the company abandoned the technology a few years ago when it was teetering on the verge of bankruptcy, according to a new investigation from IEEE Spectrum . Now, if something goes wrong with the implants, users are left stranded. “It is fantastic technology and a lousy company,” Ross Doerr, a Second Sight patient, told IEEE Spectrum . Second Sight’s implants, the Argus I and the Argus II, don’t restore normal vision; people see things in shades of gray that disappear when they move their heads. And results vary from person to person. Some users of the implants, which rolled out a decade ago, have struggled to make out even basic shapes. Others are now able to do things like ski. People who received the implants were told that there would be future updates and improvements to the technology, like software updates to boost the number of pixels in the system and thermal imaging, IEEE Spectrum reported this week.
   Haemonetics, Second Sight top healthcare gainers; Pulse, Karyopharm lead losers  2022/02/08 15:01:31 Seeking Alpha
Haemonetics HAE +13%. Second Sight Medical Products EYES +8%. Pulse Biosciences (PLSE) -36%. Karyopharm Therapeutics KPTI -22%.
   Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical  2022/02/08 11:33:09 Benzinga
Second Sight Medical Products Inc (NASDAQ: EYES ) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction . Second Sight Medical develops implantable visual prosthetics. Under the agreement, Nano Precision Medical will merge with a wholly-owned subsidiary of Second Sight . The surviving company Nano Precision Medical will be owned by Second Sight. The newly-formed merged company will focus on developing innovative implants Full story available on Benzinga.com
   Second Sight Medical Products to acquire Nano Precision Medical in all-stock deal  2022/02/07 21:53:18 Seeking Alpha
Second Sight Medical Products (EYES) will acquire Nano Precision Medical (NPM) and merge it with a wholly-owned subsidiary in an all-stock transaction.EYES will issue ~134M shares…
   Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company  2022/02/07 21:30:00 Business Wire
LOS ANGELES & EMERYVILLE, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and devi
   Go read this dystopian story about patients whose bionic eyes went obsolete  2022/02/16 20:41:55 The Verge
A patient with the Argus II. | Photo by Dunyagoz Hospital/Anadolu Agency/Getty Images More than 350 blind people around the world have implants in their eyes made by the company Second Sight Medical Products , which could help partially restore aspects of sight. But the company abandoned the technology a few years ago when it was teetering on the verge of bankruptcy, according to a new investigation from IEEE Spectrum . Now, if something goes wrong with the implants, users are left stranded. “It is fantastic technology and a lousy company,” Ross Doerr, a Second Sight patient, told IEEE Spectrum . Second Sight’s implants, the Argus I and the Argus II, don’t restore normal vision; people see things in shades of gray that disappear when they move their heads. And results vary from person to person. Some users of the implants, which rolled out a decade ago, have struggled to make out even basic shapes. Others are now able to do things like ski. People who received the implants were told that there would be future updates and improvements to the technology, like software updates to boost the number of pixels in the system and thermal imaging, IEEE Spectrum reported this week.
   Haemonetics, Second Sight top healthcare gainers; Pulse, Karyopharm lead losers  2022/02/08 15:01:31 Seeking Alpha
Haemonetics HAE +13%. Second Sight Medical Products EYES +8%. Pulse Biosciences (PLSE) -36%. Karyopharm Therapeutics KPTI -22%.
   Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical  2022/02/08 11:33:09 Benzinga
Second Sight Medical Products Inc (NASDAQ: EYES ) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction . Second Sight Medical develops implantable visual prosthetics. Under the agreement, Nano Precision Medical will merge with a wholly-owned subsidiary of Second Sight . The surviving company Nano Precision Medical will be owned by Second Sight. The newly-formed merged company will focus on developing innovative implants Full story available on Benzinga.com
   Second Sight Medical Products to acquire Nano Precision Medical in all-stock deal  2022/02/07 21:53:18 Seeking Alpha
Second Sight Medical Products (EYES) will acquire Nano Precision Medical (NPM) and merge it with a wholly-owned subsidiary in an all-stock transaction.EYES will issue ~134M shares…
   Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company  2022/02/07 21:30:00 Business Wire
LOS ANGELES & EMERYVILLE, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and devi

 関連キーワード  (― 米国株 EYESW Second Sight Medical Products Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)